The AHA, joined by the Association of American Medical Colleges and several member hospitals, yesterday asked the full U.S. Court of Appeals for the District of Columbia Circuit to rehear a July 17 decision by a three-judge panel that upheld the authority of the Department of Health and Human Services to reduce payments for hospital outpatient services furnished in off-campus provider-based departments grandfathered under the Bipartisan Budget Act of 2015. The panel upheld the payment reduction as a reasonable exercise of the agency’s statutory authority to control unnecessary increases in service volumes, relying on the legal theory announced in Chevron U.S.A. Inc. v. Natural Resources Defense Council Inc. (1984) that instructs a court to defer to such reasonable agency interpretation.  
 
Reversing a lower court decision in hospitals’ favor, the panel “sustained a draconian Centers for Medicare & Medicaid Services rulemaking by granting extraordinary deference to the agency that it neither sought nor earned,” the petitioners state. “To reach this result, the panel gave the wrong answer to several important, recurring Chevron questions.” They continue, “This case is not just important in the Chevron abstract. It is critically important in the here-and-now. It permits the Executive to unilaterally cut hundreds of millions of dollars from hospital outpatient clinics serving millions of patients across the country. Those deep cuts will be felt all the more now, as hospitals navigate the unprecedented challenges imposed by the pandemic.”

Related News Articles

Headline
Aetna’s new “level of severity inpatient payment” policy is now set to take effect Jan. 1, 2026, the company recently announced, along with providing…
Blog
Public
The health care field has entered a period of disruption, from sweeping coverage changes to the rise of artificial intelligence (AI)-enabled tools. The…
Chairperson's File
Public
In last month’s Chair File, we talked about some of the key priorities the AHA has for the remainder of 2025, one of which is protecting the 340B Drug Pricing…
Headline
The Centers for Medicare & Medicaid Services is launching a new initiative for state Medicaid programs to purchase prescription drugs at prices aligned…
Headline
The AHA and a coalition of organizations yesterday urged House and Senate leaders to pass the Reforming and Enhancing Sustainable Updates to Laboratory Testing…
Headline
The Health Resources and Services Administration posted on its website that it had approved eight drug company plans for participation in the 340B Rebate Model…